Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Autoclave Sealing Parts Withstand 4 Months Aggressive In-situ Testing

Published: Friday, October 18, 2013
Last Updated: Friday, October 18, 2013
Bookmark and Share
DuPont™ Kalrez® 6230 perfluoroelastomer seals from Dichtomatik.

Autoclaves are widely used to sterilize equipment with high pressure saturated steam at temperatures of 121°C or more. These conditions can be maintained for 15 to 20 minutes, depending upon the size of the system load and the contents.

Pressurized, high temperature steam is, however, one of the most aggressive operating environments, but this is necessary to achieve the high level of operating sterility and purity within the autoclave.

In between system loads, autoclaves are also subject to continuous cleaning cycles at high pressure/temperature steam conditions.

Typical autoclave applications include pharmaceuticals, microbiology, medicine, veterinary and mycology sciences, together with dentistry and general laboratories.

A growing application covers the pre-disposal treatment and sterilization of waste material, including pathogenic hospital waste to neutralize potentially infectious agents.

Because of such challenging applications, it is of paramount importance that autoclave components withstand the operating conditions.

Autoclaves can contain in excess of 200 seals that need to maintain their performance in hot pressurized saturated steam, as well as also being FDA and USP Class VI compliant.

The DuPont™ Kalrez® 6230 perfluoroelastomer (FFKM) seals have been developed to meet such unique requirements while providing excellent sealing qualities to comply with modern pharmaceutical processes.

These products are available from the UK authorized distributor Dichtomatik Ltd, and reduce extractables to trace levels while providing excellent steam cycling resistance up to 260°C.

Where in-situ tests have been conducted with saturated steam at 4 bar pressure and 140°C temperature, the Kalrez® 6230 seal parts performed well over a 4 month test duration of 8 hours per day and 5 days per week.

At the end of the test period, the seals exhibited little or no cracks and only minor compression set when compared to competitive perfluoroelastomer (FFKM and FKM) materials.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More than 5,000+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Automated Patch Clamping Trends
Learn more about current practices, preferences and metrics in ion channel drug screening using APC technology.
Fly Study into Therapies for HVP-Induced Cancer
Fruit flies may help scientists understand the mechanism by which HPV can cause cancer as well as identify potential drug treatments.
World's Most In-Depth Study to Detect Alzheimer's Disease
A multisite team will see the most thorough and vigorous testing for Alzheimer's ever performed on volunteers.
'Missing Evolutionary Link' of Natural Drug Source Found
Scripps Florida study finds 'missing evolutionary link' of a widely used natural drug source
Grad Student's Finding Enables Rapid Compound Screening
Grad student makes technical leap that could enable rapid screening of anti-cancer compounds.
Uncovering Constructor Proteins
Scientists have discovered a new bacterial cell wall builder that could be a target for antibiotic development.
Cholesterol Linked to Aggressive Cancers
Research suggests fats, such as cholesterol, can increase aggressive cancer progression.
Biomarker Breakthrough Could Improve Parkinson’s Treatment
A new method of tracking Parkinson's progression could aid evaluation of new and experimental treatments to slow or stop the disease.
Targeting Neglected Diseases
New enzyme-mapping advancement could help drug development for combating diseases in the developing world.
How Parkinson’s Disease Alters Brain Activity Over Time
The NIH study provides a new tool for testing experimental medications aimed at alleviating symptoms and slowing the rate at which the diseases damage the brain.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!